Biocon Biologics Announces Divestment Of Two Non core Branded Formulations - BW Businessworld

Total transaction value of the divestment is INR 3,660 million, inclusive of working capital conveyed as part of the deal, and represents an accretive multiple of 4x on Revenues and 22x on EBITDA, , Biocon Biologics

Related Keywords

India ,Amit Bakshi ,Shreehas Tambe ,Biocon Biologics ,Biocon ,Eris Lifesciences ,Branded Formulations ,Managing Director ,Biocon Biologic Nephrology ,Dermatology Branded Formulations , ,